Clinical Trials Directory

Trials / Completed

CompletedNCT07442110

This Observational Study Evaluates the Clinical Outcomes of Patients With Diabetes Who Utilize a Specialized Dietary Supplements for Foot Ulcer Healing. The Study Documents the Rate of Complete Wound Closure and the Prevention of Lower Extremity Amputations in a Real-world, At-home Setting.

Observational Study of a Specialized Dietary Supplements on the Healing of Diabetic Foot Ulcers and Prevention of Amputations

Status
Completed
Phase
Study type
Observational
Enrollment
35 (actual)
Sponsor
Amar h Zireg · Academic / Other
Sex
All
Age
25 Years
Healthy volunteers
Not accepted

Summary

This observational study evaluates the clinical outcomes of patients with diabetes who utilize a specialized dietary supplements for foot ulcer healing. The study documents the rate of complete wound closure and the prevention of lower extremity amputations in a real-world, at-home setting.

Detailed description

Context: Observation of patients with chronic diabetes mellitus and foot ulcers (Wagner stages 1-5). Observation: Data collection on the administration of daily nutritional supplements. Assessment: Weekly monitoring of tissue viability ( granulation tissue growth), reduction in inflammation, and drainage. Observed Outcomes: Documentation of complete healing rates and limb salvage in high-risk cases where amputation was previously indicated

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDiabetic foot ulcer treatment by dietary supplementsIntervention Type: Dietary Supplement Intervention Name: Diabetic Foot Ulcer Nutritional Protocol Description: A specific regimen of daily dietary supplements designed to support metabolic health and accelerated tissue repair in diabetic patients. The protocol involves the administration of targeted nutrients known to enhance collagen synthesis, reduce systemic inflammation.Participants consume the supplements orally on a daily basis over a 6-week period. The observation focuses on the supplement's ability to facilitate complete wound closure (epithelialization) and salvage limbs in patients previously scheduled for amputation. Study Status: Completed (s

Timeline

Start date
2025-07-05
Primary completion
2025-09-02
Completion
2025-09-30
First posted
2026-03-02
Last updated
2026-03-04

Locations

1 site across 1 country: Algeria

Source: ClinicalTrials.gov record NCT07442110. Inclusion in this directory is not an endorsement.